Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the involvement of cerebral microvascular endothelial Na+/K+-ATPase and Na+-K+-2Cl- co-transporter in electrolyte fluxes in an in vitro blood-brain barrier model of dehydration.
Lykke K, Assentoft M, Hørlyck S, Helms HC, Stoica A, Toft-Bertelsen TL, Tritsaris K, Vilhardt F, Brodin B, MacAulay N. Lykke K, et al. J Cereb Blood Flow Metab. 2019 Mar;39(3):497-512. doi: 10.1177/0271678X17736715. Epub 2017 Oct 10. J Cereb Blood Flow Metab. 2019. PMID: 28994331 Free PMC article.
Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy.
Brandt C, Seja P, Töllner K, Römermann K, Hampel P, Kalesse M, Kipper A, Feit PW, Lykke K, Toft-Bertelsen TL, Paavilainen P, Spoljaric I, Puskarjov M, MacAulay N, Kaila K, Löscher W. Brandt C, et al. Among authors: lykke k. Neuropharmacology. 2018 Dec;143:186-204. doi: 10.1016/j.neuropharm.2018.09.025. Epub 2018 Sep 21. Neuropharmacology. 2018. PMID: 30248303
Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204].
Brandt C, Seja P, Töllner K, Römermann K, Hampel P, Kalesse M, Kipper A, Feit PW, Lykke K, Toft-Bertelsen TL, Paavilainen P, Spoljaric I, Puskarjov M, MacAulay N, Kaila K, Löscher W. Brandt C, et al. Among authors: lykke k. Neuropharmacology. 2018 Dec;143:349-350. doi: 10.1016/j.neuropharm.2018.10.012. Epub 2018 Oct 19. Neuropharmacology. 2018. PMID: 30343990 No abstract available.
Vasopressin receptors V1a and V2 are not osmosensors.
Lykke K, Assentoft M, Fenton RA, Rosenkilde MM, MacAulay N. Lykke K, et al. Physiol Rep. 2015 Aug;3(8):e12519. doi: 10.14814/phy2.12519. Physiol Rep. 2015. PMID: 26311834 Free PMC article.
[Når der opstår mistanke om omsorgssvigt].
Lykke K. Lykke K. Ugeskr Laeger. 2021 Jul 12;183(28):V205069. Ugeskr Laeger. 2021. PMID: 34356012 Free article. Danish. No abstract available.
51 results